Net shares · 365d
-920.0K
0 buy · 920.0K sell
Net value · 365d
-$3.7M
$0 in · $3.7M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
7
0 buy · 920.0K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
RXRX Grant·A
Director
$0
88.4K sh
Own +1%
-
RXRX Sell·S
Director · 10b5-1
$110.4K
30.0K sh · $3.68
Own -0%
-
RXRX Sell·S
Director · 10b5-1
$105.6K
30.0K sh · $3.52
Own -0%
-
RXRX Sell·S
Director · 10b5-1
$93.0K
30.0K sh · $3.10
Own -0%
-
RXRX Sell·S
Director · 10b5-1
$588.2K
170.0K sh · $3.46
Own -3%
-
RXRX Sell·S
Director · 10b5-1
$924.0K
220.0K sh · $4.20
Own -3%
-
RXRX Sell·S
Director · 10b5-1
$959.2K
220.0K sh · $4.36
Own -3%
-
RXRX Sell·S
Director · 10b5-1
$961.4K
220.0K sh · $4.37
Own -3%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | RXRX | Grant A | 88.4K | $0 |
| Jun 2, 2026 | RXRX | Sell S | 30.0K | $110.4K |
| May 5, 2026 | RXRX | Sell S | 30.0K | $105.6K |
| Apr 7, 2026 | RXRX | Sell S | 30.0K | $93.0K |
| Mar 3, 2026 | RXRX | Sell S | 170.0K | $588.2K |
| Feb 3, 2026 | RXRX | Sell S | 220.0K | $924.0K |
| Jan 6, 2026 | RXRX | Sell S | 220.0K | $959.2K |
| Dec 2, 2025 | RXRX | Sell S | 220.0K | $961.4K |
Buy Sell Non-market (grant · exercise · gift)
About Borgeson Blake
This profile aggregates every SEC Form 4 insider transaction reported by Borgeson Blake across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.